Optimising the health of young people with HIV in their transition from paediatric to adult care
The aim of the CHIPS+ cohort is to evaluate the longer-term health outcomes of young people in adult care who have HIV acquired in childhood
What is this study about?
Due to improvements in HIV treatment and care, increasing numbers of children living with HIV are surviving into adulthood and transitioning from paediatric to adult care. Nevertheless, data collection in CHIPS (the Collaborative HIV Paediatric Study) ceases at time of transfer to adult care. Thus there is a substantial knowledge gap about long term health outcomes of this group in the UK and Ireland, and worldwide; through CHIPS+ we aim to bridge this gap.
Type of study
Who is funding the study?
CHIPS+ is linked to CHIPS and is funded via participation in European ART safety studies, themselves funded by pharmaceutical companies.
When is it taking place?
July 2017 to December 2020
Where is it taking place?
NHS clinics across the UK and Ireland
Who is included?
Patients aged ≥15 years who received paediatric HIV care in the UK or Ireland.